Ligustrazine monomer against cerebral ischemia/reperfusion injury

查看全文 作　　者：Hai-jun [1,2]Gao;Peng-fei [1]Liu;Pei-wen [1]Li;Zhuo-yan [3]Huang;Feng-bo [4]Yu;Ting [1]Lei;Yong [1]Chen;Ye [1]Cheng;Qing-chun [2]Mu;Hai-yan [1]Huang

机构地区：[1]Department of Neurosurgery,First Bethune Hospital of Jilin University;[2]Department of Neurosurgery,Hongqi Hospital of Mudanjiang Medical University;[3]Clinical Medical College of Beihua University;[4]School of Pharmacy,Mudanjiang Medical University

出　　处：《Neural Regeneration Research》索引2015年第10卷第5期,共9页

基　　金：supported by a grant from the Health and Family Planning Commission of Heilongjiang Province Research Project in China,No.2014-195;the Education Department Science and Technology Foundation of Heilongjiang Province in China,No.12531741;the Natural Science Foundation of Heilongjiang Province of China,No.H2015083 摘　　要：Ligustrazine(2,3,5,6-tetramethylpyrazine) is a major active ingredient of the Szechwan lovage rhizome and is extensively used in treatment of ischemic cerebrovascular disease.The mechanism of action of ligustrazine use against ischemic cerebrovascular diseases remains unclear at present.This study summarizes its protective effect,the optimum time window of administration,and the most effective mode of administration for clinical treatment of cerebral ischemia/reperfusion injury.We examine the effects of ligustrazine on suppressing excitatory amino acid release,promoting migration,differentiation and proliferation of endogenous neural stem cells.We also looked at its effects on angiogenesis and how it inhibits thrombosis,the inflammatory response,and apoptosis after cerebral ischemia.We consider that ligustrazine gives noticeable protection from cerebral ischemia/reperfusion injury.The time window of ligustrazine administration is limited.The protective effect and time window of a series of derivative monomers of ligustrazine such as 2-[(1,1-dimethylethyl)oxidoimino]methyl]-3,5,6-trimethylpyrazine,CXC137 and CXC195 after cerebral ischemia were better than ligustrazine. 关键词：缺血/再灌注损伤脑血管病川芎嗪单体保护作用时间窗口兴奋性氨基酸行政管理

相关文献

参考文献（87）
引证文献（56）
耦合文献（245）

参考文献(87)

引证文献(56)

耦合文献(245)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Ligustrazine monomer against cerebral ischemia/reperfusion injury

参考文献(87)

引证文献(56)

耦合文献(245)

用户提示